Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia

Relapse of acute myeloid leukemia (AML) is still dramatically frequent, imposing the need for early markers to quantify such risk. Recent evidence point to a prominent role for extracellular matrix (ECM) in AML, but its prognostic value has not yet been investigated. Here we have investigated whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Izzi, Valerio, Lakkala, Juho, Devarajan, Raman, Savolainen, Eeva-Riitta, Koistinen, Pirjo, Heljasvaara, Ritva, Pihlajaniemi, Taina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735295/
https://www.ncbi.nlm.nih.gov/pubmed/29270355
http://dx.doi.org/10.1016/j.lrr.2017.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735295/
https://www.ncbi.nlm.nih.gov/pubmed/29270355
http://dx.doi.org/10.1016/j.lrr.2017.12.001

Ejemplares similares